MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cynosure Company Profile (NASDAQ:CYNO)

Consensus Ratings for Cynosure (NASDAQ:CYNO) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $51.20 (7.38% upside)

Analysts' Ratings History for Cynosure (NASDAQ:CYNO)
Show:
DateFirmActionRatingPrice TargetActions
4/27/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016Maxim GroupBoost Price TargetBuy$52.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2016Stifel NicolausBoost Price TargetBuy$44.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/4/2016Northland SecuritiesReiterated RatingBuy$46.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2015Northcoast ResearchInitiated CoverageBuy$41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Tigress FinancialInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2014Citigroup Inc.Reiterated RatingBuy$35.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Cynosure (NASDAQ:CYNO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016        
4/26/2016Q116$0.14$0.19$85.78 million$94.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2016Q415$0.38$0.42$95.01 million$102.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315$0.18$0.21$76.68 million$78.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q215$0.29$0.30$82.71 million$83.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q1$0.09$0.15$70.87 million$74.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2015Q414$0.39$0.36$83.01 million$86.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2014Q314$0.24$0.25$69.94 million$71.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214$0.29$0.32$71.15 million$72.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q1$0.23$0.19$64.70 million$62.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2014Q413$0.19$0.39$67.80 million$74.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313$0.19$0.23$61.60 million$60.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.20$0.29$46.96 million$50.09 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2013Q1 2013$0.13$0.12$38.51 million$10.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2013Q4 2012$0.23$0.27$40.98 million$47.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2012$0.12$0.25ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2012$0.12$0.20ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012($0.02)$0.06ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2012$0.05$0.08ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011$0.04($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($0.05)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2011($0.03)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Cynosure (NASDAQ:CYNO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.13$0.26$0.18
Q2 20165$0.27$0.37$0.31
Q3 20165$0.21$0.35$0.30
Q4 20165$0.51$0.74$0.60
Q1 20172$0.24$0.33$0.29
Q2 20172$0.42$0.49$0.46
Q3 20172$0.31$0.41$0.36
Q4 20172$0.69$0.88$0.79
(Data provided by Zacks Investment Research)
Dividend History for Cynosure (NASDAQ:CYNO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Cynosure (NASDAQ:CYNO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/13/2016Douglas J DelaneyVPSell12,299$46.60$573,133.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Michael R DavinCEOSell26,271$46.59$1,223,965.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Timothy W BakerCFOSell12,451$46.60$580,216.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016Douglas J DelaneyVPSell15,890$45.01$715,208.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016Michael R DavinCEOSell74,729$45.31$3,385,970.99View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016Timothy W BakerCFOSell14,008$45.02$630,640.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2016Douglas J DelaneyVPSell24,488$45.02$1,102,449.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2016Michael R DavinCEOSell61,377$45.01$2,762,578.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2016Timothy W BakerCFOSell39,857$45.02$1,794,362.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2016Michael R DavinCEOSell72$45.00$3,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Douglas J DelaneyVPSell4,408$45.08$198,712.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Michael R DavinCEOSell4,869$45.11$219,640.59View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Timothy W BakerCFOSell4,413$45.08$198,938.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Douglas J DelaneyVPSell66,626$45.47$3,029,484.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Michael R DavinCEOSell66,259$45.61$3,022,072.99View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Timothy W BakerCFOSell53,297$45.60$2,430,343.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2015Michael R. DavinCEOSell200$45.00$9,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2015Timothy W. BakerCFOSell100$45.00$4,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Ettore V BiagioniDirectorSell24,000$36.25$870,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Douglas J DelaneyVPSell89,000$38.01$3,382,890.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Michael R DavinCEOSell151,000$38.07$5,748,570.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/23/2015Michael R DavinCEOSell6,991$33.04$230,982.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2015Michael R DavinCEOSell44,677$33.01$1,474,787.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2015Douglas J DelaneyVPSell28,335$33.01$935,338.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2015Michael R DavinCEOSell70,000$32.00$2,240,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2015Douglas J DelaneyVPSell45,000$32.00$1,440,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Ettore V BiagioniDirectorSell12,000$30.09$361,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014Ettore V BiagioniDirectorSell2,500$28.00$70,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014Ettore V BiagioniDirectorSell5,000$27.28$136,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2013Marina HatsopoulosDirectorBuy3,000$22.60$67,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2012Douglas J DelaneyVPSell16,904$27.65$467,395.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2012Michael R DavinCEOSell16,770$27.65$463,690.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2012Timothy W BakerCFOSell16,854$27.65$466,013.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Cynosure (NASDAQ:CYNO)
DateHeadline
06/29/16 03:30 PMHow Analysts Feel About Cynosure, Inc. (NASDAQ:CYNO)? - Press Telegraph
06/29/16 09:04 AMRadio Frequency Beauty Equipment Market Forecast By End-use Industry 2015-2025
06/28/16 03:30 PMCynosure, Inc. (NASDAQ:CYNO) Earnings Glance and Target Price Review - Engelwood Daily
06/28/16 03:30 PMShare Update and Earnings Review for Cynosure, Inc. (NASDAQ:CYNO) - Press Telegraph
06/28/16 11:05 AMCynosure, Inc. :CYNO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 -
06/27/16 03:31 PMStock Performance Focus on: Cynosure, Inc. (NASDAQ:CYNO) - Press Telegraph
06/27/16 08:02 AMSkincare Devices Market – OTC skincare products is expected to impede market growth.
06/25/16 07:22 AMStock Tracing Lower on the Week Cynosure, Inc. (NASDAQ:CYNO) - Engelwood Daily
06/24/16 10:16 AMCynosure, Inc. (NASDAQ:CYNO) Updated Price Targets - FTSE News
06/23/16 08:14 AMFMI: Directed Energy-Based Surgical Systems Market Forecast By End-use Industry 2015-2025
06/22/16 08:46 PMCynosure, Inc. Stock Momentum Hits Strength - CML News
06/21/16 08:14 AMPeter Thiel To Continue As Facebook Director (FB)
06/20/16 03:27 PMCynosure, Inc. (NASDAQ:CYNO) Accounts Payable Is $25.931 For The Quarter Ended 2016-03-31 - RealistInvestor.com
06/16/16 08:49 PMGlobal Scar Treatment Market will reach at a CAGR of 3.8% during 2016 – 2024
06/16/16 07:53 AMCynosure, Inc. (CYNO) - Financial and Strategic SWOT Analysis Review - New Market Report
06/16/16 07:30 AMCynosure to Ring NASDAQ Stock Market Closing Bell to Celebrate 25 Year Anniversary - [PR Newswire] - WESTFORD, Mass., June 16, 2016 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today announced that President and CEO Michael Davin, along with other members of the Company's management team, will ring ...
06/13/16 11:00 AMETF’s with exposure to Cynosure, Inc. : June 13, 2016 -
06/12/16 09:49 AMCynosure, Inc. (NASDAQ:CYNO) Has $0.167 Millions Outstanding Debt Accrued - RealistInvestor.com
06/10/16 09:38 AMCynosure Inc. (CYNO) Hits New 52-week High During June 08 Session - Equities.com
06/09/16 03:35 PMRadio Frequency Beauty Equipment Market with Current Trends Analysis,2015-2025
06/09/16 10:49 AM4 Stocks To Watch: CETX, CYNO, ECOM, GLOG
06/09/16 10:49 AMGlobal Scar Treatment Market Expected to Grow at 10% CAGR During 2016 - 2022: P&S Market Research
06/06/16 03:21 PMCYNOSURE INC. (NASDAQ:CYNO) Financial Condition Compared to S&P 500 - CML News
06/05/16 08:50 PMPerformance Review for Cynosure, Inc. (NASDAQ:CYNO) - HNN
06/03/16 10:28 AMComing Around On Cynosure - Seeking Alpha
06/02/16 09:36 PMCynosure Inc. (CYNO) is Trading Higher on Unusual Volume for June 01 - Equities.com - Cynosure Inc. (CYNO) is Trading Higher on Unusual Volume for June 01Equities.comCynosure Inc. (CYNO) experienced unusually high volume on Jun. 01, as the stock gained 5.69% to a closing price of $50.49. The stock saw 777,223 shares trade hands over the course of the day on 5,070 trades. Given that the stock's average daily volume ...and more »
06/02/16 03:41 PMCynosure, Inc. (NASDAQ:CYNO) Stock Update & Estimates - Stock Tick Tock - Cynosure, Inc. (NASDAQ:CYNO) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting Cynosure, Inc. (NASDAQ:CYNO) to post earnings of $0.29 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be issued around ...
06/01/16 09:41 PMCynosure Inc. (CYNO) Jumps 5.69% on June 01 - Equities.com - Cynosure Inc. (CYNO) Jumps 5.69% on June 01Equities.comCynosure Inc. (CYNO) was among the biggest gainers on the Russell 2000 for Wednesday June 01 as the stock popped 5.69% to $50.49, representing a gain of $2.72 per share. Some 777,223 shares traded hands on 5,070 trades, compared with an average ...and more »
06/01/16 03:41 PMCynosure Inc A (CYNO) Strong On High Relative Volume Today - TheStreet.com - TheStreet.comCynosure Inc A (CYNO) Strong On High Relative Volume TodayTheStreet.comTrade-Ideas LLC identified Cynosure Inc A ( CYNO) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Cynosure Inc A as such a stock due to the following factors: CYNO has an average ...and more »
05/31/16 09:16 PMInsight Capital Research & Management INC Increased Cynosure INC (NASDAQ:CYNO) by $3.99 Million as Shares ... - CCH Daily News - Insight Capital Research & Management INC Increased Cynosure INC (NASDAQ:CYNO) by $3.99 Million as Shares ...CCH Daily NewsInsight Capital Research & Management Inc increased its stake in Cynosure Inc (NASDAQ:CYNO) by 279.24% based on its latest 2016Q1 regulatory filing with the SEC. Insight Capital Research & Management Inc bought 90,760 shares as the company's ...and more »
05/31/16 04:11 AMStock Review and Earnings Check on Cynosure, Inc. (NASDAQ:CYNO) - HNN - Stock Review and Earnings Check on Cynosure, Inc. (NASDAQ:CYNO)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Cynosure, Inc. (NASDAQ:CYNO) to ...and more »
05/26/16 12:15 PMBroker Roundup For Cynosure, Inc. (NASDAQ:CYNO) - Share Trading News - Broker Roundup For Cynosure, Inc. (NASDAQ:CYNO)Share Trading News09/16/2015 – Cynosure, Inc. had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 45 price target on the stock. 04/29/2015 – Northcoast Research began new coverage on Cynosure, Inc. giving the company a “buy” rating.New Analyst Ratings On Cynosure, Inc. (NASDAQ:CYNO)Risers & FallersFDA clears new wavelength for Cynosure's aesthetic laserSeeking AlphaCynosure Gets FDA Clearance for New 1064 NM PicoSure Aesthetic Laser (NASDAQ:CYNO)Sonoran Weekly ReviewPR Newswire (press release) -Benzingaall 6 news articles »
05/26/16 12:15 PMNotable Two Stocks to Monitor: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) , Cynosure, Inc. (NASDAQ:CYNO) - Street Updates - Notable Two Stocks to Monitor: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) , Cynosure, Inc. (NASDAQ:CYNO)Street UpdatesOn 5/25/2016, shares of Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) rose +1.8661% in trading session and finally closed at $0.8352. The company most recent volume stood at 312.41 thousand shares as compared to its average volume of 585.12 ...and more »
05/25/16 07:46 AMCynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer - [at noodls] - WESTFORD, Mass., May 25, 2016 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today announced that Timothy W. Baker has notified the Company that he plans to retire to pursue philanthropic interests. Mr. ...
05/25/16 07:41 AMCYNOSURE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits -
05/24/16 09:25 AMCynosure Gets FDA Approval To Market New PicoSure Energy Delivery System For Tattoos And Pigmented Lesions - Cynosure, Inc. (NASDAQ: CYNO) said Tuesday it received Food and Drug Administration 510(k) approval to market a new Laser Delivery System for PicoSure, the world's first aesthetic picosecond laser. According to the company, it would broaden its product platform for tattoo removal and skin revitalization. Cynosure said that along with the FDA cleared 532 nm and 755 nm wavelengths, its new 1064 nm Laser Delivery System enhances the multi-wavelength laser technology for removing the full color spectrum of tattoo inks in fewer treatments. Commenting ...Full story available on Benzinga.com
05/24/16 07:46 AMCynosure Receives FDA Clearance to Market New PicoSure® Energy Delivery System for Tattoos and Pigmented Lesions - [at noodls] - WESTFORD, Mass., May 24, 2016 /PRNewswire/ -- Broadening its product platform for tattoo removal and skin revitalization, Cynosure, Inc. (NASDAQ: CYNO) today announced that it has received U.S. Food and ...
05/19/16 12:04 PMCYNOSURE INC Financials -
05/16/16 05:40 PMCYNOSURE INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matte -
05/14/16 08:21 AMHealthcare Stock Latest Update: Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) , Cynosure, Inc. (NASDAQ:CYNO) - Is stories - Is storiesHealthcare Stock Latest Update: Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) , Cynosure, Inc. (NASDAQ:CYNO)Is storiesPacira Pharmaceuticals, Inc. (NASDAQ:PCRX) decreased -1.26% to $43.21 while traded 909.58 thousand shares on 5/13/2016. The stock price negotiated for value between $42.82 to $44.54 in recent trading session. During the past 52 weeks, the stock's ...
05/13/16 08:50 AMCynosure, Inc. (NASDAQ:CYNO) One-Year Mean Price Target At $56.285 - Investor Newswire - Cynosure, Inc. (NASDAQ:CYNO) One-Year Mean Price Target At $56.285Investor NewswireSell-side analysts are confident on the future outlook of Cynosure, Inc. (NASDAQ:CYNO) stock. As of 2016-05-11, the stock has an ABR of 1 rating, where number 5 denotes a Strong Sell and 1 Strong Buy. The ABR is reached on the basis of estimates of 7 ...and more »
05/13/16 08:50 AMStocks within Traders Radar: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) , Cynosure, Inc. (NASDAQ:CYNO) - Street Updates - Stocks within Traders Radar: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) , Cynosure, Inc. (NASDAQ:CYNO)Street UpdatesOn 5/12/2016, Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) ended trading session lower at $129.62 with -5.58%. The company traded a volume of 548.14 thousand shares as comparison to average volume of 653.8 thousand shares. During the 52 –week ...and more »
05/12/16 09:07 AMConsensus Rating Review for Cynosure, Inc. (NASDAQ:CYNO) - B.O.D.Y Confidential - Consensus Rating Review for Cynosure, Inc. (NASDAQ:CYNO)B.O.D.Y ConfidentialEquity research analysts currently have a consensus rating of 1 on shares of Cynosure, Inc. (NASDAQ:CYNO). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy, Sell, or Hold ...and more »
05/10/16 05:25 PMCYNOSURE INC Files SEC form 10-Q, Quarterly Report -
05/09/16 02:12 PMETF’s with exposure to Cynosure, Inc. : May 9, 2016 -
05/09/16 08:23 AMAfter Last Week What Do Analysts Think Of Cynosure, Inc. (NASDAQ:CYNO) - Share Trading News - After Last Week What Do Analysts Think Of Cynosure, Inc. (NASDAQ:CYNO)Share Trading News09/16/2015 – Cynosure, Inc. had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 45 price target on the stock. 04/29/2015 – Northcoast Research began new coverage on Cynosure, Inc. giving the company a “buy” rating.and more »
05/06/16 08:39 AMCynosure, Inc. (NASDAQ:CYNO) ABR Of 1 - Investor Newswire - Cynosure, Inc. (NASDAQ:CYNO) ABR Of 1Investor NewswireThere are numerous brokerages operating in the market, and each one of them uses a different process to prepare the research reports on a stock. As a result, investors have to study more than one research report before taking an investment call on a stock.and more »
05/06/16 08:39 AMTraded Price Fluctuations to Observe: Cambrex Corporation (NYSE:CBM) , Cynosure, Inc. (NASDAQ:CYNO) - Street Updates - Traded Price Fluctuations to Observe: Cambrex Corporation (NYSE:CBM) , Cynosure, Inc. (NASDAQ:CYNO)Street UpdatesCynosure, Inc. (NASDAQ:CYNO) moved in green zone with rise of +2.27 points or +4.83% to $49.29. The company has a market worth of $1.12B.Total 519.74 thousand shares were exchanged in last trading session as opposed to average volume of 306.42 ...and more »
05/05/16 08:35 AMCynosure Inc. (CYNO) is Trading Lower on Unusual Volume for May 03 - Equities.com - Cynosure Inc. (CYNO) is Trading Lower on Unusual Volume for May 03Equities.comCynosure Inc. (CYNO) experienced unusually high volume on May. 03, as the stock lost 2.53% to a closing price of $47.02. The stock saw 646,270 shares trade hands over the course of the day on 5,478 trades. Given that the stock's average daily volume ...and more »
05/04/16 07:08 AMAverage Analyst Rating for Cynosure, Inc. (NASDAQ:CYNO) - B.O.D.Y Confidential - Average Analyst Rating for Cynosure, Inc. (NASDAQ:CYNO)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1 on Cynosure, Inc. (NASDAQ:CYNO) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
About Cynosure

Cynosure logoCynosure Inc. develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve vaginal health. The Company also markets radiofrequency (RF) energy sourced medical devices for precision surgical applications, such as facial plastic and general surgery; gynecology; ear, nose and throat procedures; ophthalmology; oral and maxillofacial surgery; podiatry, and proctology. The Company offers single energy source systems as well as workstations that incorporate two or more different types of lasers or pulsed light technologies.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: CYNO
  • CUSIP: 23257720
Key Metrics:
  • Previous Close: $47.68
  • 50 Day Moving Average: $48.49
  • 200 Day Moving Average: $43.30
  • P/E Ratio: 58.86
  • P/E Growth: 1.70
  • Market Cap: $1.12B
  • Current Quarter EPS Consensus Estimate: $1.29 EPS
Additional Links:
Cynosure (NASDAQ:CYNO) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha